New Treatments for Perimenopause: Estrigenix’s Promising Drug Targeted at Hot Flashes and Memory Decline
Hot flashes are a common life disruptor in perimenopause, as is cognitive decline in later life. Dr. Karyn Frick, Distinguished Professor of Psychology at the University of Wisconsin-Milwaukee and Chief |Scientific Officer of Estrigenix, is working to create a non-hormonal solution to both problems. We discuss the science behind discoveries that could change the quality of life for women as they age as well as the long pathway that a drug goes through to get to market.
Beyond The Paper Gown Podcast · Mitzi Krockover, MD
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Hot flashes are a common life disruptor in perimenopause, as is cognitive decline in later life. Dr. Karyn Frick, Distinguished Professor of Psychology at the University of Wisconsin-Milwaukee and Chief |Scientific Officer of Estrigenix, is working to create a non-hormonal solution to both problems. We discuss the science behind discoveries that could change the quality of life for women as they age as well as the long pathway that a drug goes through to get to market.